*By Conor White* Though he sued Mark Zuckerberg for stealing the idea for Facebook, Divya Narendra said he's excited about the future of the social media giant, and sees Facebook as a good investment. "If you have a long-term mindset, this is probably one of the cheapest stocks you can own," said Narendra in an interview Thursday with Cheddar's Kristen Scholer and Brad Smith. "On a price-to-earnings basis, or on a price-to-growth basis, really versus any other stock in this sort of large cap universe." Narendra hit Zuckerberg with an intellectual property suit for allegedly stealing the idea for Facebook while the two were students at Harvard. They settled in 2009 for around $65 million ー $20 million in cash and 1.25 million Facebook shares. Despite that antagonistic history, Narendra is bullish on Zuckerberg's company. "You saw a 15 to 20 percent drop in the stock off of bad PR, which is I think a solvable problem," said Narendra. "I guess that's how the markets work, but clearly an overreaction." Narendra is the chief executive of SumZero, an investment website for professional investors. For the full interview, [click here](https://cheddar.com/videos/facebook-looks-to-future-after-beating-earnings-expectations).

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More